Our team

Pharvaris was founded in October 2015 by former executives of Jerini AG and Prosensa NV, forming a seasoned team with experience in rare diseases and hereditary angioedema (HAE). The Pharvaris team brings from the onset the full range of expertise needed for successful drug development and value creation: drug discovery, pre-clinical and clinical drug development, finance, business development, and commercial.

Management & Founders

Management

Board

Scientific Advisors